NASDAQ:SRRK - Scholar Rock News Headlines

$10.76
-1.20 (-10.03 %)
(As of 08/25/2019 04:00 PM ET)
Today's Range
$11.64
Now: $10.76
$12.49
50-Day Range
$10.34
MA: $12.53
$15.77
52-Week Range
$9.30
Now: $10.76
$30.00
Volume73,595 shs
Average Volume112,638 shs
Market Capitalization$319.36 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.01

Headlines

Scholar Rock (NASDAQ SRRK) News Headlines

Source:
DateHeadline
Wedbush Weighs in on Scholar Rock Holding Corps Q3 2019 Earnings (NASDAQ:SRRK)Wedbush Weighs in on Scholar Rock Holding Corp's Q3 2019 Earnings (NASDAQ:SRRK)
www.americanbankingnews.com - August 19 at 1:34 AM
Scholar Rock Holding Corp Forecasted to Earn Q3 2019 Earnings of ($0.44) Per Share (NASDAQ:SRRK)Scholar Rock Holding Corp Forecasted to Earn Q3 2019 Earnings of ($0.44) Per Share (NASDAQ:SRRK)
www.americanbankingnews.com - August 19 at 1:34 AM
Scholar Rock (SRRK) Presents At Wedbush PacGrow Healthcare Conference - SlideshowScholar Rock (SRRK) Presents At Wedbush PacGrow Healthcare Conference - Slideshow
seekingalpha.com - August 15 at 4:01 PM
Scholar Rock (NASDAQ:SRRK) Issues  Earnings ResultsScholar Rock (NASDAQ:SRRK) Issues Earnings Results
www.americanbankingnews.com - August 15 at 11:20 AM
 Brokerages Anticipate Scholar Rock Holding Corp (NASDAQ:SRRK) Will Announce Quarterly Sales of $5.38 Million Brokerages Anticipate Scholar Rock Holding Corp (NASDAQ:SRRK) Will Announce Quarterly Sales of $5.38 Million
www.americanbankingnews.com - August 15 at 5:20 AM
Scholar Rock Reports Second Quarter 2019 Financial Results and Highlights Business ProgressScholar Rock Reports Second Quarter 2019 Financial Results and Highlights Business Progress
finance.yahoo.com - August 14 at 11:05 AM
 Brokerages Anticipate Scholar Rock Holding Corp (NASDAQ:SRRK) to Post -$0.41 Earnings Per Share Brokerages Anticipate Scholar Rock Holding Corp (NASDAQ:SRRK) to Post -$0.41 Earnings Per Share
www.americanbankingnews.com - August 13 at 4:58 AM
Scholar Rock to Present at the 2019 Wedbush PacGrow Healthcare ConferenceScholar Rock to Present at the 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 7 at 6:51 PM
Did Changing Sentiment Drive Scholar Rock Holdings (NASDAQ:SRRK) Share Price Down By 19%?Did Changing Sentiment Drive Scholar Rock Holding's (NASDAQ:SRRK) Share Price Down By 19%?
finance.yahoo.com - June 26 at 3:51 PM
Did Changing Sentiment Drive Scholar Rock Holding's (NASDAQ:SRRK) Share Price Down By 19%?Did Changing Sentiment Drive Scholar Rock Holding's (NASDAQ:SRRK) Share Price Down By 19%?
finance.yahoo.com - June 26 at 3:51 PM
Scholar Rock prices 3M-share offering at $15 eachScholar Rock prices 3M-share offering at $15 each
seekingalpha.com - June 19 at 9:00 PM
Scholar Rock Announces Pricing of Public Offering of Common StockScholar Rock Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - June 19 at 9:00 PM
Scholar Rock readies stock offeringScholar Rock readies stock offering
seekingalpha.com - June 19 at 11:38 AM
Scholar Rock to Present at the 2019 BMO Prescriptions for Success Healthcare ConferenceScholar Rock to Present at the 2019 BMO Prescriptions for Success Healthcare Conference
finance.yahoo.com - June 19 at 11:38 AM
Scholar Rock Announces Proposed Public Offering of Common StockScholar Rock Announces Proposed Public Offering of Common Stock
finance.yahoo.com - June 18 at 6:15 PM
Scholar Rock Holding (SRRK) Presents At 2019 Jefferies Global Healthcare Conference - SlideshowScholar Rock Holding (SRRK) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow
seekingalpha.com - June 6 at 4:01 PM
Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy VolunteersScholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers
finance.yahoo.com - June 4 at 11:53 AM
Scholar Rock to Present at the Jefferies 2019 Global Healthcare ConferenceScholar Rock to Present at the Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 29 at 11:22 AM
Scholar Rock beats by $0.08, misses on revenueScholar Rock beats by $0.08, misses on revenue
seekingalpha.com - May 15 at 11:43 AM
Scholar Rock Reports First Quarter 2019 Financial Results and Highlights Business ProgressScholar Rock Reports First Quarter 2019 Financial Results and Highlights Business Progress
finance.yahoo.com - May 14 at 4:13 PM
Is Scholar Rock Holding Corporation (SRRK) A Good Stock To Buy?Is Scholar Rock Holding Corporation (SRRK) A Good Stock To Buy?
finance.yahoo.com - May 10 at 11:56 AM
Scholar Rock Announces Initiation of Patient Dosing in Phase 2 Trial of SRK-015 in Spinal Muscular AtrophyScholar Rock Announces Initiation of Patient Dosing in Phase 2 Trial of SRK-015 in Spinal Muscular Atrophy
finance.yahoo.com - May 9 at 11:54 AM
Scholar Rock Announces Appointment of Lisa Amaya Price as Senior Vice President, Human ResourcesScholar Rock Announces Appointment of Lisa Amaya Price as Senior Vice President, Human Resources
finance.yahoo.com - April 11 at 8:23 AM
Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGFβ1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination TherapyScholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGFβ1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy
finance.yahoo.com - April 2 at 4:25 PM
Scholar Rock Reports Full Year 2018 Financial Results and Highlights Business ProgressScholar Rock Reports Full Year 2018 Financial Results and Highlights Business Progress
finance.yahoo.com - March 19 at 10:49 AM
Scholar Rock to Develop Cancer Immunotherapy Product Candidate, SRK-181, a Selective Inhibitor of TGFβ1 Activation, to Overcome Checkpoint Inhibitor ResistanceScholar Rock to Develop Cancer Immunotherapy Product Candidate, SRK-181, a Selective Inhibitor of TGFβ1 Activation, to Overcome Checkpoint Inhibitor Resistance
finance.yahoo.com - March 12 at 6:50 PM
Scholar Rock to Participate in Upcoming Investor ConferencesScholar Rock to Participate in Upcoming Investor Conferences
feeds.benzinga.com - March 6 at 7:32 AM
Scholar Rocks SRK-015 shows positive action in early-stage study; shares up 2%Scholar Rock's SRK-015 shows positive action in early-stage study; shares up 2%
seekingalpha.com - February 26 at 12:46 PM
Scholar Rock Announces Positive Interim Results from Phase 1 Trial of SRK-015 in Healthy Volunteers and Updates on Future Development PlansScholar Rock Announces Positive Interim Results from Phase 1 Trial of SRK-015 in Healthy Volunteers and Updates on Future Development Plans
finance.yahoo.com - February 26 at 12:46 PM
Scholar Rock (SRRK) Presents At 37th Annual J.P. Morgan Healthcare Conference - SlideshowScholar Rock (SRRK) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 10 at 3:32 PM
Read This Before Selling Scholar Rock Holding Corporation (NASDAQ:SRRK) SharesRead This Before Selling Scholar Rock Holding Corporation (NASDAQ:SRRK) Shares
finance.yahoo.com - January 4 at 3:34 PM
3 Biopharma Stocks to Buy for Their Robust Dividend Yields3 Biopharma Stocks to Buy for Their Robust Dividend Yields
investorplace.com - January 3 at 12:45 PM
Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare ConferenceScholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 11:16 AM
Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD DealBiotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal
finance.yahoo.com - December 26 at 11:01 AM
Scholar Rock Holding Corporation (SRRK)Scholar Rock Holding Corporation (SRRK)
www.zacks.com - December 21 at 11:04 AM
Gilead Sciences, Scholar Collaborate On Novel Therapies For Fibrotic DiseasesGilead Sciences, Scholar Collaborate On Novel Therapies For Fibrotic Diseases
www.nasdaq.com - December 19 at 11:16 AM
Scholar Rock teams up with Gilead in fibrotic diseases in partnership valued as high as $1.5BScholar Rock teams up with Gilead in fibrotic diseases in partnership valued as high as $1.5B
seekingalpha.com - December 19 at 11:16 AM
Gilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic DiseasesGilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic Diseases
finance.yahoo.com - December 19 at 11:16 AM
Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular AtrophyScholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy
finance.yahoo.com - December 4 at 10:24 AM
Scholar Rock to Present at the BMO 2018 Prescriptions for Success Healthcare ConferenceScholar Rock to Present at the BMO 2018 Prescriptions for Success Healthcare Conference
finance.yahoo.com - November 30 at 10:10 AM
Scholar Rock Announces Publication of Preclinical Data on the Therapeutic Benefit of Inhibiting Myostatin Activation in Models of Spinal Muscular AtrophyScholar Rock Announces Publication of Preclinical Data on the Therapeutic Benefit of Inhibiting Myostatin Activation in Models of Spinal Muscular Atrophy
finance.yahoo.com - November 27 at 10:23 AM
Scholar Rock Holding Corp. (SRRK) Reports New Preclinical Data from TGFB1 Cancer Immunotherapy ProgramScholar Rock Holding Corp. (SRRK) Reports New Preclinical Data from TGFB1 Cancer Immunotherapy Program
www.streetinsider.com - November 13 at 9:30 AM
Scholar Rock Demonstrates that Highly Specific TGFβ1 Inhibition Combined with Anti-PD1 Drives Tumor Regression and Survival Benefit in Preclinical Models of Primary Resistance to Checkpoint Blockade TherapyScholar Rock Demonstrates that Highly Specific TGFβ1 Inhibition Combined with Anti-PD1 Drives Tumor Regression and Survival Benefit in Preclinical Models of Primary Resistance to Checkpoint Blockade Therapy
finance.yahoo.com - November 9 at 9:40 AM
Scholar Rock to Present at the Jefferies 2018 London Healthcare ConferenceScholar Rock to Present at the Jefferies 2018 London Healthcare Conference
finance.yahoo.com - October 31 at 9:19 AM
Scholar Rock to Present Preclinical Data Highlighting the Role of TGFβ1 Inhibition in Overcoming Checkpoint Resistance at the SITC Annual MeetingScholar Rock to Present Preclinical Data Highlighting the Role of TGFβ1 Inhibition in Overcoming Checkpoint Resistance at the SITC Annual Meeting
finance.yahoo.com - October 2 at 8:43 AM
Pfizers domagrozumab exit in DMD pressures Scholar Rock, down 9%Pfizer's domagrozumab exit in DMD pressures Scholar Rock, down 9%
seekingalpha.com - August 30 at 3:19 PM
Scholar Rock: Value Waiting To Be Unlocked In This May IPOs PipelineScholar Rock: Value Waiting To Be Unlocked In This May IPO's Pipeline
seekingalpha.com - August 21 at 7:28 AM
Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business ProgressScholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress
finance.yahoo.com - August 9 at 7:12 AM
Kaskela Law LLC Announces Investigation of Scholar Rock Holding Corp. on Behalf of StockholdersKaskela Law LLC Announces Investigation of Scholar Rock Holding Corp. on Behalf of Stockholders
finance.yahoo.com - June 21 at 3:16 PM
[$$] Eidos Therapeutics Goes Public, Joining Biotech IPO Flurry[$$] Eidos Therapeutics Goes Public, Joining Biotech IPO Flurry
finance.yahoo.com - June 21 at 5:46 AM
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Featured Article: Oversold

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel